Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single Centre Study Evaluating The Diagnostic Performance of Spectra IMDx System for The Detection of Gastric Cancer and Precancerous Lesions In Vivo

NCT04835246 is registered in ClinicalTrials.gov with Endofotonics Pte Ltd as lead sponsor.

NCT NCT04835246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04835246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single Centre Study Evaluating The Diagnostic Performance of Spectra IMDx System for The Detection of Gastric Cancer and Precancerous Lesions In Vivo
Lead sponsor
Endofotonics Pte Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
October 7, 2019
Completion date
July 31, 2021
Enrollment
185 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, gastric precancerous lesion